Clinical Trial Update: Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav [Phase 4]

View source ↗

Summary

Phase 4 clinical trial showing successful transition of uncontrolled glaucoma patients from prior monotherapy or adjunctive therapy to DuoTrav.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• DuoTrav (travoprost; timolol (fixed-dose combination))

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma | Phase 4 | Status: COMPLETED